Expect a Limited Role for Basal Insulin/GLP-1 Agonist Combo Products

June 2017

New combo products will raise questions about when to use basal insulin with a GLP-1 agonist for type 2 diabetes.

Combining a GLP-1 agonist (Victoza, etc) and basal insulin (Lantus, etc) may be an alternative to increasing the basal insulin dose...or adding mealtime insulin.

This "insulin-sparing" approach leads to less weight gain than a similar dose of basal insulin alone...with similar hypoglycemia risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Antithrombotics Consider Switching Some VTE Patients to a Low-Dose Direct Oral Anticoagulant
Ear Health Use Antibiotic Drops Instead of Oral Antibiotics for Kids With Ear Tubes
Migraine Consider "Mini-Prophylaxis" for Some Women With Menstrual Migraine
Acute Pain Dispel the Myth That Ketorolac Is a Stronger NSAID
Psychiatry Have an "Exit Plan" for Antipsychotics in Dementia Patients
Opioids Avoid Codeine and Tramadol in Kids and Breastfeeding Women
PPIs Know When Short- or Long-Term Use of PPIs Is Appropriate
Diabetes Meds Expect a Limited Role for Basal Insulin/GLP-1 Agonist Combo Products
Fibromyalgia Emphasize Nondrug Measures for Fibromyalgia
Psychiatry Consider Ingrezza When Treatment Is Needed for Tardive Dyskinesia

Expect a Limited Role for Basal Insulin/GLP-1 Agonist Combo Products

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents